1. Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia
- Author
-
Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo’, Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, and Adalgisa Condoluci
- Subjects
Cancer Research ,Settore MED/15 - MALATTIE DEL SANGUE ,Oncology ,dose intensity ,ibrutinib ,chronic lymphocytic leukemia ,Humans ,Hematology ,General Medicine ,Leukemia, Lymphocytic, Chronic, B-Cell - Published
- 2022